Passage BIO (PASG) Common Equity (2019 - 2026)
Passage BIO (PASG) reported Common Equity of $4.46 million for Q2 2026, down 88.4% from $38.26 million a year earlier and down 62.1% from the prior quarter.
Powered by 
Analysis
Passage BIO (PASG) Common Equity (2019 - 2026) Analysis & Trends
At the end of FY2025, Passage BIO posted Common Equity of $18.76 million, down 69.4% from FY2024.
- Common Equity has declined for four consecutive years, with a five-year compound annual growth rate of -42.7% (FY2020 to FY2025).
- By year, Common Equity came in at $61.26 million in FY2024 (-45.0%), $111.28 million in FY2023 (-44.7%), $201.37 million in FY2022 (-36.8%) and $318.66 million in FY2021 (+4.6%).
- The Q2 2026 figure ranks as the lowest quarterly Common Equity since Q4 2019.
- Year over year, Common Equity has now declined in each of the last 18 quarters, with an average decline of 61.3% over the last eight quarters.
- The high point for year-over-year Common Equity in five years was Q3 2021 (growth of 6.9%); the low point was Q2 2026 (a decline of 88.4%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $11.75 million (Q1 2026), $18.76 million (Q4 2025) and $31.12 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 84.97 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | -5.94 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 41.98 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 41.95 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 50.37 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 11.69 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 11.83 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 85.49 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 20.25 Bn |
| 10 | Passage BIO | 14.48 Mn | 14.48 Mn | - | 4.46 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 4.46 Mn |
| Mar 31, 2026 | 11.75 Mn |
| Dec 31, 2025 | 18.76 Mn |
| Sep 30, 2025 | 31.12 Mn |
| Jun 30, 2025 | 38.26 Mn |
| Mar 31, 2025 | 46.71 Mn |
| Dec 31, 2024 | 61.26 Mn |
| Sep 30, 2024 | 72.72 Mn |
| Jun 30, 2024 | 90.56 Mn |
| Mar 31, 2024 | 104.88 Mn |
| Dec 31, 2023 | 111.28 Mn |
| Sep 30, 2023 | 126.28 Mn |
| Jun 30, 2023 | 150.41 Mn |
| Mar 31, 2023 | 170.35 Mn |
| Dec 31, 2022 | 201.37 Mn |
| Sep 30, 2022 | 224.40 Mn |
| Jun 30, 2022 | 248.05 Mn |
| Mar 31, 2022 | 281.31 Mn |
| Dec 31, 2021 | 318.66 Mn |
| Sep 30, 2021 | 362.23 Mn |
API Access
Passage BIO Common Equity API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=common-equity&ticker=PASG&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "common-equity", "ticker": "PASG", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=common-equity&ticker=PASG&period=max&api_key=YOUR_API_KEY");
const data = await res.json();